Discover more from PsyMed Ventures Newsletter
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness
Neuromodulation flies in the face of modern psychiatry. It can significantly improve mental health without drugs. It allows us to stimulate or inhibit activity in precise regions of the brain using electricity, magnetism or ultrasound.
Motif Neurotech is pioneering minimally invasive implants to precisely deliver neuromodulation for mental health. In this special episode, Matias joins Empath Ventures’ Brom Rector to interview Jacob Robinson, an entrepreneurial scientist who leveraged his academic research to start Motif Neurotech.
PsyMed Ventures and Empath Ventures invested in Motif’s latest seed round. Motif's implantable device stimulates a region of the brain associated with depression. Other applications being explored include Alzheimer's disease, PTSD and ADHD.
Neuromodulation is still early but holds great promise as a paradigm shift in psychiatry and even human augmentation–unlocking the full potential of the brain.
In this episode we discuss:
Motif’s minimally invasive bioelectronic technology
The future of the neurotech market
Leveraging academic connections to attract top-notch talent
The challenges and opportunities of transitioning from professor to founder
Once you've finished the episode, we'd love to hear your thoughts! Tweet us at @psymedventures to share your views.
P.S. Do you know someone who would enjoy the Business Trip by PsyMed Ventures podcast? Feel free to share this newsletter by clicking the link below and hitting the ❤️ button on this post to help us reach more people on Substack 🙏